Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-31 @ 4:06 AM
Study NCT ID:
NCT00926068
Status:
UNKNOWN
Last Update Posted:
2013-04-04
First Post:
2009-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'removedCountries': ['Israel']}, 'conditionBrowseModule': {'meshes': [{'id': 'D017719', 'term': 'Diabetic Foot'}, {'id': 'D003920', 'term': 'Diabetes Mellitus'}, {'id': 'D016523', 'term': 'Foot Ulcer'}], 'ancestors': [{'id': 'D003925', 'term': 'Diabetic Angiopathies'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D007871', 'term': 'Leg Ulcer'}, {'id': 'D012883', 'term': 'Skin Ulcer'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D048909', 'term': 'Diabetes Complications'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}, {'id': 'D003929', 'term': 'Diabetic Neuropathies'}, {'id': 'D044882', 'term': 'Glucose Metabolism Disorders'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D005534', 'term': 'Foot Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 196}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2010-02'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2013-04', 'lastUpdateSubmitDate': '2013-04-03', 'studyFirstSubmitDate': '2009-06-22', 'studyFirstSubmitQcDate': '2009-06-22', 'lastUpdatePostDateStruct': {'date': '2013-04-04', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2009-06-23', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2013-08', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Complete ulcer closure', 'timeFrame': 'Up to 14 weeks inclusive', 'description': 'Time to Event Analysis that determines time for incidence of 100% study wound closure per unit of time (days) and the incidence of 100% wound closure per unit of time using the log rank test.'}], 'secondaryOutcomes': [{'measure': 'Percent change in wound area at 4 weeks', 'timeFrame': '4 weeks'}, {'measure': '75% wound closure by or on Study Week 14', 'timeFrame': 'Up to 14 weeks inclusive'}, {'measure': 'Incidence of adverse events, changes in vital signs, physical examination, electrocardiogram and laboratory tests from baseline to termination.', 'timeFrame': '14 weeks'}, {'measure': 'Incidence of 100% Closure tested by the Fisher exact 2-tailed test', 'timeFrame': 'Up to 14 weeks inclusive'}, {'measure': 'Percent change in granulation tissue at 4 weeks', 'timeFrame': '4 weeks'}, {'measure': 'Incidence of improved ulcers'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Diabetes Mellitus', 'Foot Ulcer', 'DFU', 'Wound healing'], 'conditions': ['Diabetic Foot Ulcer']}, 'descriptionModule': {'briefSummary': 'A prospective, double blind, randomized, placebo controlled, outpatient, parallel group comparison trial to assess the safety and efficacy of HO/03/03 10µg versus Placebo, applied topically once daily for up to 14 weeks in at least 196 subjects diagnosed with Diabetes Mellitus and having a single target non-healing Plantar Neuropathic Diabetic Foot Ulcer.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '80 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Age between 18 and 80 years, extremes included\n2. Diagnosed with Diabetes Mellitus Type 1 or Type 2\n3. Having a documented single target non-healing Plantar Neuropathic Diabetic Foot Ulcer with a minimal duration of 4 weeks prior to the informed consent signature\n4. Ulcer size at randomization:\n\n * Wagner grade 1, between 2.0 cm2 to 10 cm2, extremes included or;\n * Wagner grade 2, between 1.0 cm2 to 10 cm2, extremes included;\n5. Single target, ulcer on the study foot:\n\n * Wagner grade 1 or;\n * Wagner grade 2 (does not involve abscess or osteomyelitis);\n6. Target ulcer area decreased by ≤ 30% OR ≤ 0.1 cm/wk edge healing rate measured after debridement at screening to after debridement if clinically indicated at randomization.\n7. Glycosylated Haemoglobin A1c (HbA1c) ≤ 12%;\n8. Ankle to Brachial Index (ABI) on study foot:\n\n * 0.7 ≤ ABI ≤ 1.2 or\n * ABI \\> 1.2 and toe pressure \\> 50 mm Hg (ABI measured by Doppler; toe blood pressure measured by toe cuff);\n9. Diabetic Neuropathy is confirmed by neurological testing\n10. Subject should be available for the entire study period, and be able and willing to adhere to protocol requirements\n11. Subject has signed the informed consent form prior to any study protocol related procedure\n\nExclusion Criteria:\n\nSubjects meeting one or more of the following criteria cannot be selected:\n\n1. Anamnesis of current or recent past (within the last 2 years) abuse of alcohol, barbiturates, benzodiazepines, amphetamines, narcotics, cocaine, psychoactive drugs or other abused substances that will interfere with treatment compliance\n2. Use of growth factors, skin graft or participation in an investigational study within the last 30 days prior to the beginning of the screening period\n3. Females who are pregnant, lactating, of child-bearing potential, or post-menopausal for less than 2 years and not using a medically approved method of contraception or females who test positive on a blood-based pregnancy test\n4. Have a documented medical history of HIV, HBV or HCV\n5. Have a documented medical history of a significant cardiac, pulmonary, gastrointestinal, endocrine (other than Diabetes Mellitus type 1 or 2), metabolic, neurological, hepatic or nephrologic disease and/or receiving dialysis\n6. Anaemia (Haemoglobin \\< 9 gram/dL for females or Haemoglobin \\< 10 gram/dL for males) or White Blood Cells count \\> 11,000/μL or Platelets count \\< 100,000/μL or impaired renal function (Creatinine \\> 3 mg/dL) or liver function tests \\> 3 times upper normal lab values or any indication of malnourishment (Albumin \\< 2.8 g/dL) or any other clinically significant biochemistry, haematology and urinalysis tests;\n7. Had any clinically significant illness during the last 4 weeks prior to the screening period;\n8. Have a current malignancy or a past malignancy in the last 5 years other than Basal Cell Carcinoma or is treated by radio/chemotherapy\n9. Have any signs of clinical infection in the wound (which could be linked to raised body temperature, abscess, osteomyelitis, necrosis or erythema)\n10. Had any antibiotic treatment during the screening period;\n11. Had evidence of infection or osteomyelitis on a plain foot x-ray at screening;\n12. Is bed-ridden or unable to come to the clinic;\n13. Have more than one target non-healing Diabetic Foot Ulcer per subject;\n14. Plantar Neuropathic DFU is located on an active Charcot foot;\n15. Have hind foot ulcer or have a foot deformity/condition preventing the use of offload footwear;\n16. Had a leg revascularization surgery within the last 6 months or be a candidate for revascularization surgery during the course of the study;\n17. Glucocorticosteroid treatment (Prednisone \\>10 mg/day or its equivalent)\n18. Inability to stop alternative wound healing treatment (e.g. Becaplermin or other topical products) following debridement'}, 'identificationModule': {'nctId': 'NCT00926068', 'acronym': 'Truheal', 'briefTitle': 'Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers', 'organization': {'class': 'INDUSTRY', 'fullName': 'HealOr'}, 'officialTitle': 'Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal)', 'orgStudyIdInfo': {'id': 'HO-09-01'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'HO/03/03 10µg', 'interventionNames': ['Drug: HO/03/03 10µg']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'interventionNames': ['Drug: Placebo']}], 'interventions': [{'name': 'HO/03/03 10µg', 'type': 'DRUG', 'armGroupLabels': ['HO/03/03 10µg']}, {'name': 'Placebo', 'type': 'DRUG', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '85012', 'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'Phoenix VA Healthcare System', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '94546', 'city': 'Castro Valley', 'state': 'California', 'country': 'United States', 'facility': 'Center For Clinical Research', 'geoPoint': {'lat': 37.6941, 'lon': -122.08635}}, {'zip': '90822', 'city': 'Long Beach', 'state': 'California', 'country': 'United States', 'facility': 'Dr. Ian Gordon', 'geoPoint': {'lat': 33.76696, 'lon': -118.18923}}, {'zip': '90010', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Advanced Clinical Research', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90063', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Innovative Medical Technologies, LLC', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '94609', 'city': 'Oakland', 'state': 'California', 'country': 'United States', 'facility': 'California School of Podiatric Medicine at Samuel Merritt University', 'geoPoint': {'lat': 37.80437, 'lon': -122.2708}}, {'zip': '06515', 'city': 'New Haven', 'state': 'Connecticut', 'country': 'United States', 'facility': 'North American Centre for Limb Preservation', 'geoPoint': {'lat': 41.30815, 'lon': -72.92816}}, {'zip': '33744', 'city': 'Bay Pines', 'state': 'Florida', 'country': 'United States', 'facility': 'Bay Pines VA Healthcare System-Wound Clinic Bay Pines VA Healthcare System-Research Pharmacy', 'geoPoint': {'lat': 27.81419, 'lon': -82.77816}}, {'zip': '33136', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'University of Miami Miller School of Medicine', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33143', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Doctors Research Network', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '60064', 'city': 'North Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'Capt. James A. Lovell Federal Health Care Center', 'geoPoint': {'lat': 42.32558, 'lon': -87.84118}}, {'zip': '47713', 'city': 'Evansville', 'state': 'Indiana', 'country': 'United States', 'facility': 'Deaconess Clinic Downtown-Research Institute', 'geoPoint': {'lat': 37.97476, 'lon': -87.55585}}, {'zip': '46032', 'city': 'Indianapolis', 'state': 'Indiana', 'country': 'United States', 'facility': 'St. Vincent Wound Care Center IDI Research', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '02139', 'city': 'Cambridge', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Cambridge Hospital', 'geoPoint': {'lat': 42.3751, 'lon': -71.10561}}, {'zip': '10461', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Center for Curative & Palliative Wound Care Calvary Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '16201', 'city': 'Kittanning', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Armstrong County Memorial Hospital Snyder Institute for Vascular Health and Research', 'geoPoint': {'lat': 40.81645, 'lon': -79.52199}}, {'zip': '19103', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Paddington Testing Company', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '17403', 'city': 'York', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Martin Foot and Ankle', 'geoPoint': {'lat': 39.9626, 'lon': -76.72774}}, {'zip': '78501', 'city': 'McAllen', 'state': 'Texas', 'country': 'United States', 'facility': 'Complete Family Foot Care', 'geoPoint': {'lat': 26.20341, 'lon': -98.23001}}, {'zip': '122001', 'city': 'Gurgaon', 'state': 'Haryana', 'country': 'India', 'facility': 'Medanta', 'geoPoint': {'lat': 28.4601, 'lon': 77.02635}}, {'zip': '560052', 'city': 'Bangalore', 'state': 'Karnataka', 'country': 'India', 'facility': 'Jain Institute of Vascular Sciences', 'geoPoint': {'lat': 12.97194, 'lon': 77.59369}}, {'zip': '560069', 'city': 'Bangalore', 'state': 'Karnataka', 'country': 'India', 'facility': 'Karnataka Institute of Diabetology', 'geoPoint': {'lat': 12.97194, 'lon': 77.59369}}, {'zip': '580034', 'city': 'Bangalore', 'state': 'Karnataka', 'country': 'India', 'facility': "St.John's Hospital", 'geoPoint': {'lat': 12.97194, 'lon': 77.59369}}, {'zip': '59001', 'city': 'Belagavi', 'state': 'Karnataka', 'country': 'India', 'facility': 'Belgaum Diabetes Centre', 'geoPoint': {'lat': 15.85212, 'lon': 74.50447}}, {'zip': '575003', 'city': 'Mangalore', 'state': 'Karnataka', 'country': 'India', 'facility': 'Vinaya Hospital and Research Centre', 'geoPoint': {'lat': 12.91723, 'lon': 74.85603}}, {'zip': '680 503', 'city': 'Thrissur', 'state': 'Kerala', 'country': 'India', 'facility': 'Kunnamkulam Eye and Diabetes Centre', 'geoPoint': {'lat': 10.51667, 'lon': 76.21667}}, {'zip': '411033', 'city': 'Pune', 'state': 'Maharashtra', 'country': 'India', 'facility': 'OM Shree Swami Samarth Hospital', 'geoPoint': {'lat': 18.51957, 'lon': 73.85535}}, {'zip': '411051', 'city': 'Pune', 'state': 'Maharashtra', 'country': 'India', 'facility': 'Patil Hospital', 'geoPoint': {'lat': 18.51957, 'lon': 73.85535}}, {'zip': '600013', 'city': 'Chennai', 'state': 'Tamil Nadu', 'country': 'India', 'facility': 'MV Hospital for Diabetes Pvt Ltd', 'geoPoint': {'lat': 13.08784, 'lon': 80.27847}}, {'zip': '600029', 'city': 'Chennai', 'state': 'Tamil Nadu', 'country': 'India', 'facility': 'Dr. V Seshiah Diabetes Research Institute', 'geoPoint': {'lat': 13.08784, 'lon': 80.27847}}, {'zip': '632004', 'city': 'Vellore', 'state': 'Tamil Nadu', 'country': 'India', 'facility': 'Christian Medical College', 'geoPoint': {'lat': 12.9184, 'lon': 79.13255}}, {'zip': '700009', 'city': 'Kolkata', 'state': 'West Bengal', 'country': 'India', 'facility': 'SK Diabetes Research & Education Center', 'geoPoint': {'lat': 22.56263, 'lon': 88.36304}}, {'city': 'Kolkata', 'country': 'India', 'facility': 'Advanced Medicare & Research Institute', 'geoPoint': {'lat': 22.56263, 'lon': 88.36304}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'HealOr', 'class': 'INDUSTRY'}, 'collaborators': [{'name': 'Clinigene International Ltd', 'class': 'INDUSTRY'}, {'name': 'Cato Research', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}